Could a simple patch beat pills for Post-Surgery bladder pain?

NCT ID NCT03952299

Recruiting now Symptom relief Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a skin patch that delivers oxybutynin works better than oral pills to reduce bladder pain and urgency in children after bladder surgery. About 100 children aged 4 to 8 will be enrolled. The goal is to see if the patch provides better relief and reduces the need for narcotic painkillers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Oxybutynin (Ditropan XL) given as a transdermal patch or oral pill
What this could lead to: If it works, this could point toward a better way to manage bladder pain and urgency after surgery in children, possibly reducing the need for strong painkillers.
What could go wrong: This is a small, early-phase trial with only 100 children, so results may not apply to everyone. The patch might not be more effective than the pill, and side effects like skin irritation or drowsiness are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROPATHIC BLADDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hinman syndrome overactive bladder Urinary Bladder, Neurogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROPATHIC BLADDER OVERACTIVE BLADDER SYNDROME

Contacts and locations

Locations

University of California Davis Medical Center (UCDMC)
RECRUITING

Sacramento, California, 95817, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.